Portfolio Holdings Detail for ISIN IE00B53SZB19
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares NASDAQ 100 UCITS ETF USD (Acc)
Issuer Blackrock

ETF Ticker CNX1(GBX) LSE
ETF Ticker SXRV(EUR) F
ETF Ticker CNDX.AS(EUR) CXE
ETF Ticker CNDX.LS(USD) CXE
ETF Ticker CNX1.LS(GBX) CXE
ETF Ticker CSNDX.MI(EUR) CXE
ETF Ticker CSNDXz(USD) CXE
ETF Ticker SXRV.DE(EUR) CXE
ETF Ticker CSNDX(EUR) ETF Plus
ETF Ticker CNDX(EUR) Euronext Amsterdam
ETF Ticker CNX1.L(GBP) LSE

Holdings detail for DXCM

Stock Name	DexCom Inc
Ticker	DXCM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US2521311074
LEI	549300YSK3QDSFR5EU59

Show aggregate DXCM holdings

News associated with DXCM

Implied QQEW Analyst Target Price: $156: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 07:55:44
Friday's ETF with Unusual Volume: QQH: The HCM Defender 100 Index ETF is seeing unusually high volume in afternoon trading Friday, with over 190,000 shares traded versus three month average volume of about 26,000. Shares of QQH were up about 0.6% on the day. Components of that ETF with the highest volume on Friday - 2025-09-19 13:23:32
Nasdaq 100 Movers: DXCM, FTNT: In early trading on Friday, shares of Fortinet topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.7%. Year to date, Fortinet has lost about 11.9% of its value. And the worst performing Nasdaq 100 component thus far on the day is DexCo - 2025-09-19 12:11:42
DexCom, Inc. (NASDAQ:DXCM) Receives $99.89 Consensus Price Target from Brokerages: Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and three have given a strong buy […] - 2025-09-18 03:01:05
Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside: When it comes to identifying target stocks for investment, compelling prospects may include companies that are undervalued and, simultaneously, expected to appreciate in the future. Of course, timing an investment in one of these firms is notoriously difficult. It may help to lo - 2025-09-14 11:27:00
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 13:38:14
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:43:18
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:13:06
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 10:36:17
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:39:38
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:27:13
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 06:09:22
DexCom (NASDAQ:DXCM) Downgraded by Oppenheimer to Market Perform: Oppenheimer cut shares of DexCom (NASDAQ:DXCM – Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Monday, MarketBeat.com reports. Other research analysts have also recently issued research reports about the stock. Argus assumed coverage on shares of DexCom in a research report on Thursday, August […] - 2025-09-09 02:50:44
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-08 22:27:11
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Analysts: DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating on […] - 2025-08-21 02:41:01
Leerink Partnrs Predicts DexCom’s Q3 Earnings (NASDAQ:DXCM): DexCom, Inc. (NASDAQ:DXCM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q3 2025 earnings estimates for shares of DexCom in a report released on Wednesday, July 30th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of $0.57 per share for the quarter, down from their […] - 2025-08-04 02:46:55
DexCom (DXCM) Q2 Revenue Jumps 15%: Key PointsRevenue (GAAP) rose 15% year-over-year in Q2 2025, easily surpassing expectations and driven by strong U.S. and international growth. - 2025-08-01 01:53:01
Allianz Asset Management GmbH Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM): Allianz Asset Management GmbH lowered its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 73,079 shares of the medical device company’s stock after selling 21,698 shares during the period. Allianz Asset […] - 2025-07-29 04:42:53
DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates: Besides Wall Street's top-and-bottom-line estimates for DexCom (DXCM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025. - 2025-07-29 01:00:16
Private Advisor Group LLC Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM): Private Advisor Group LLC cut its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 13,461 shares of the medical device company’s stock after selling 1,688 shares during the period. Private Advisor Group LLC’s holdings in DexCom were worth $919,000 as of its most recent […] - 2025-07-28 05:22:58
HighPoint Advisor Group LLC Has $299,000 Holdings in DexCom, Inc. (NASDAQ:DXCM): HighPoint Advisor Group LLC cut its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,196 shares of the medical device company’s stock after selling 749 shares during the quarter. HighPoint Advisor Group LLC’s […] - 2025-07-24 05:51:13
AVLV's Underlying Holdings Imply 10% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-21 10:15:07
DexCom (NASDAQ:DXCM) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Friday. A number of other equities research analysts have also commented on the company. Cfra Research upgraded DexCom to a “hold” rating in a research report on Friday, March […] - 2025-07-21 04:58:50
Morgan Stanley Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock: DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by equities research analysts at Morgan Stanley from $82.00 to $89.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s price objective would indicate a potential upside […] - 2025-07-17 06:22:53
Cerity Partners LLC Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM): Cerity Partners LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 4.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 69,601 shares of the medical device company’s stock after acquiring an additional 2,711 shares during the period. Cerity Partners LLC’s […] - 2025-07-17 05:30:58
DexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Stratos Wealth Partners LTD.: Stratos Wealth Partners LTD. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 32.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,428 shares of the medical device company’s stock after buying an additional 845 shares during the quarter. Stratos […] - 2025-07-17 04:58:54
Allworth Financial LP Purchases 1,765 Shares of DexCom, Inc. (NASDAQ:DXCM): Allworth Financial LP lifted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 163.3% during the 1st quarter, Holdings Channel reports. The firm owned 2,846 shares of the medical device company’s stock after acquiring an additional 1,765 shares during the period. Allworth Financial LP’s holdings in DexCom were worth $201,000 at the end of […] - 2025-07-16 05:18:51
Nisa Investment Advisors LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM): Nisa Investment Advisors LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 53.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 34,228 shares of the medical device company’s stock after selling 40,004 shares during the quarter. Nisa Investment Advisors […] - 2025-07-14 05:50:57
Principal Financial Group Inc. Boosts Holdings in DexCom, Inc. (NASDAQ:DXCM): Principal Financial Group Inc. lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 804,917 shares of the medical device company’s stock after purchasing an additional 219,965 shares during the […] - 2025-07-07 08:08:45
First Horizon Advisors Inc. Has $108,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM): First Horizon Advisors Inc. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 25.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 1,582 shares of the medical device company’s stock after acquiring an additional 320 shares during the period. First Horizon Advisors Inc.’s holdings in DexCom were worth $108,000 […] - 2025-07-07 06:19:27

iShares NASDAQ 100 UCITS ETF USD (Acc) DXCM holdings

Date	Number of DXCM Shares Held	Base Market Value of DXCM Shares	Local Market Value of DXCM Shares	Change in DXCM Shares Held	Change in DXCM Base Value	Current Price per DXCM Share Held	Previous Price per DXCM Share Held
2025-09-29 (Monday)	486,581	USD 32,338,173	USD 32,338,173
2025-09-26 (Friday)	486,311	USD 32,631,468	USD 32,631,468
2025-09-25 (Thursday)	486,176	USD 33,205,821	USD 33,205,821	135	USD 398,053	USD 68.3	USD 67.5
2025-09-24 (Wednesday)	486,041	USD 32,807,768	USD 32,807,768
2025-09-18 (Thursday)	483,746	USD 36,658,272	USD 36,658,272	1,125	USD -233,277	USD 75.78	USD 76.44
2025-09-17 (Wednesday)	482,621	USD 36,891,549	USD 36,891,549	1,395	USD 53,699	USD 76.44	USD 76.55
2025-09-16 (Tuesday)	481,226	USD 36,837,850	USD 36,837,850	540	USD 507,602	USD 76.55	USD 75.58
2025-09-15 (Monday)	480,686	USD 36,330,248	USD 36,330,248
2025-09-12 (Friday)	480,236	USD 36,603,588	USD 36,603,588	0	USD 105,652	USD 76.22	USD 76

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DXCM by Blackrock for IE00B53SZB19

Show aggregate share trades of DXCM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-25 BUY 135 68.300* 79.24
2025-09-18 BUY 1,125 75.780* 79.26
2025-09-17 BUY 1,395 76.440* 79.27
2025-09-16 BUY 540 76.550* 79.29
2025-09-11 BUY 360 76.000* 79.32
2025-08-29 BUY 540 75.340* 79.37
2025-08-22 SELL -45 82.260* 79.35 Profit of 3,571 on sale
2025-08-21 SELL -180 80.620* 79.35 Profit of 14,282 on sale
2025-08-20 BUY 135 81.670* 79.33
2025-08-19 BUY 450 80.900* 79.32
2025-08-15 BUY 1,350 80.950* 79.30
2025-08-13 BUY 1,080 79.960* 79.30
2025-08-12 BUY 180 80.170* 79.29
2025-08-05 BUY 315 75.460* 79.34
2025-08-04 SELL -45 76.250* 79.36 Profit of 3,571 on sale
2025-07-31 BUY 360 80.770* 79.35
2025-07-30 BUY 360 89.060* 79.29
2025-07-28 BUY 360 89.530* 79.16
2025-07-17 SELL -546 84.100* 79.06 Profit of 43,167 on sale
2025-07-15 BUY 182 84.780* 78.99
2025-07-14 BUY 182 85.330* 78.95
2025-07-11 BUY 182 83.370* 78.92
2025-07-09 BUY 364 84.870* 78.88
2025-07-08 SELL -182 83.760* 78.85 Profit of 14,350 on sale
2025-07-02 SELL -182 83.580* 78.73 Profit of 14,329 on sale
2025-07-01 BUY 1,092 83.580* 78.70
2025-06-26 BUY 1,080 85.040* 78.60
2025-06-25 BUY 1,782 84.680* 78.55
2025-06-24 BUY 360 87.570* 78.49
2025-06-18 BUY 354 81.010* 78.45
2025-06-17 BUY 182 81.830* 78.43
2025-06-16 SELL -885 83.000* 78.40 Profit of 69,380 on sale
2025-06-13 BUY 182 81.990* 78.37
2025-06-12 SELL -728 82.850* 78.34 Profit of 57,028 on sale
2025-06-06 BUY 181 86.670* 78.13
2025-06-05 BUY 354 85.740* 78.07
2025-06-04 BUY 362 85.610* 78.01
2025-06-03 BUY 4,344 86.790* 77.94
2025-06-02 BUY 181 85.510* 77.88
2025-05-30 BUY 716 85.800* 77.82
2025-05-29 SELL -181 84.860* 77.76 Profit of 14,075 on sale
2025-05-28 SELL -181 86.980* 77.69 Profit of 14,061 on sale
2025-05-23 SELL -362 84.510* 77.51 Profit of 28,058 on sale
2025-05-22 SELL -1,448 84.830* 77.45 Profit of 112,145 on sale
2025-05-20 SELL -177 87.340* 77.30 Profit of 13,682 on sale
2025-05-19 BUY 354 86.960* 77.22
2025-05-16 BUY 181 85.480* 77.14
2025-05-15 BUY 1,641 85.670* 77.07
2025-05-14 BUY 366 86.520* 76.99
2025-05-13 BUY 1,632 84.110* 76.92
2025-05-12 BUY 1,281 85.050* 76.85
2025-05-08 BUY 549 85.340* 76.70
2025-05-02 BUY 366 81.620* 76.51
2025-04-29 BUY 732 71.300* 76.67
2025-04-28 BUY 1,269 71.180* 76.73
2025-04-25 BUY 549 71.660* 76.78
2025-04-24 BUY 366 70.780* 76.84
2025-04-23 BUY 366 66.860* 76.94
2025-04-22 BUY 1,281 66.330* 77.05
2025-04-16 BUY 366 68.730* 77.44
2025-04-15 BUY 915 69.230* 77.53
2025-04-14 BUY 2,196 67.390* 77.64
2025-04-11 BUY 720 66.140* 77.77
2025-04-09 BUY 1,980 66.840* 78.01
2025-04-08 BUY 3,600 60.690* 78.21
2025-04-04 SELL -2,347 59.830* 78.62 Profit of 184,523 on sale
2025-04-02 SELL -179 68.140* 78.75 Profit of 14,095 on sale
2025-04-01 SELL -179 67.320* 78.88 Profit of 14,120 on sale
2025-03-31 SELL -1,247 68.290* 79.01 Profit of 98,528 on sale
2025-03-26 BUY 1,609 72.130* 79.36
2025-03-25 BUY 1,981 73.550* 79.44
2025-03-24 BUY 543 75.320* 79.49
2025-03-21 BUY 11,379 73.800* 79.57
2025-03-20 BUY 358 75.110* 79.63
2025-03-19 BUY 1,396 73.380* 79.71
2025-03-18 BUY 358 70.700* 79.83
2025-03-17 SELL -537 71.350* 79.95 Profit of 42,934 on sale
2025-03-14 BUY 895 70.690* 80.08
2025-03-13 BUY 358 68.480* 80.25
2025-03-11 SELL -990 70.260* 80.53 Profit of 79,728 on sale
2025-03-10 SELL -885 70.720* 80.68 Profit of 71,402 on sale
2025-03-06 SELL -885 79.510* 80.74 Profit of 71,456 on sale
2025-03-05 SELL -352 81.960* 80.72 Profit of 28,414 on sale
2025-03-04 SELL -1,584 82.420* 80.70 Profit of 127,822 on sale
2025-03-03 SELL -829 85.990* 80.61 Profit of 66,826 on sale
2025-02-28 SELL -511 88.370* 80.48 Profit of 41,127 on sale
2025-02-25 SELL -704 88.320* 80.06 Profit of 56,361 on sale
2025-02-20 SELL -352 89.340* 79.54 Profit of 27,997 on sale
2025-02-19 SELL -1,056 89.680* 79.35 Profit of 83,793 on sale
2025-02-18 SELL -528 90.530* 79.14 Profit of 41,785 on sale
2025-02-13 BUY 352 84.090* 78.64
2025-02-07 BUY 352 88.080* 77.95
2025-01-29 BUY 704 86.430* 76.23
2025-01-28 BUY 176 88.350* 75.91
2025-01-27 SELL -17 87.530* 75.60 Profit of 1,285 on sale
2025-01-24 BUY 528 88.750* 75.23
2025-01-23 SELL -7,392 87.700* 74.88 Profit of 553,488 on sale
2025-01-22 BUY 511 87.090* 74.52
2024-12-10 BUY 181 79.410* 74.37
2024-12-09 SELL -1,267 78.410* 74.24 Profit of 94,066 on sale
2024-12-06 BUY 720 77.720* 74.13
2024-12-05 BUY 180 78.920* 73.97
2024-12-03 SELL -720 80.910* 73.47 Profit of 52,900 on sale
2024-12-02 BUY 360 79.310* 73.26
2024-11-29 BUY 532 77.990* 73.07
2024-11-27 BUY 362 78.100* 72.65
2024-11-26 BUY 181 77.940* 72.42
2024-11-22 BUY 554 72.830* 72.15
2024-11-21 BUY 181 74.460* 72.03
2024-11-19 BUY 543 74.880* 71.70
2024-11-18 BUY 2,134 76.270* 71.43
2024-11-12 BUY 720 74.340* 71.25
2024-11-08 BUY 180 69.960* 71.40
2024-11-07 BUY 4,475 68.910* 71.60
2024-11-06 BUY 537 68.610* 71.84
2024-11-05 BUY 179 69.000* 72.10
2024-11-04 BUY 360 69.700* 72.34
2024-10-25 BUY 362 73.440* 73.26
2024-10-24 SELL -362 74.850* 72.72 Profit of 26,326 on sale
2024-10-21 BUY 543 72.610* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-25	BUY	135	68.300*	79.24
2025-09-18	BUY	1,125	75.780*	79.26
2025-09-17	BUY	1,395	76.440*	79.27
2025-09-16	BUY	540	76.550*	79.29
2025-09-11	BUY	360	76.000*	79.32
2025-08-29	BUY	540	75.340*	79.37
2025-08-22	SELL	-45	82.260*	79.35 Profit of 3,571 on sale
2025-08-21	SELL	-180	80.620*	79.35 Profit of 14,282 on sale
2025-08-20	BUY	135	81.670*	79.33
2025-08-19	BUY	450	80.900*	79.32
2025-08-15	BUY	1,350	80.950*	79.30
2025-08-13	BUY	1,080	79.960*	79.30
2025-08-12	BUY	180	80.170*	79.29
2025-08-05	BUY	315	75.460*	79.34
2025-08-04	SELL	-45	76.250*	79.36 Profit of 3,571 on sale
2025-07-31	BUY	360	80.770*	79.35
2025-07-30	BUY	360	89.060*	79.29
2025-07-28	BUY	360	89.530*	79.16
2025-07-17	SELL	-546	84.100*	79.06 Profit of 43,167 on sale
2025-07-15	BUY	182	84.780*	78.99
2025-07-14	BUY	182	85.330*	78.95
2025-07-11	BUY	182	83.370*	78.92
2025-07-09	BUY	364	84.870*	78.88
2025-07-08	SELL	-182	83.760*	78.85 Profit of 14,350 on sale
2025-07-02	SELL	-182	83.580*	78.73 Profit of 14,329 on sale
2025-07-01	BUY	1,092	83.580*	78.70
2025-06-26	BUY	1,080	85.040*	78.60
2025-06-25	BUY	1,782	84.680*	78.55
2025-06-24	BUY	360	87.570*	78.49
2025-06-18	BUY	354	81.010*	78.45
2025-06-17	BUY	182	81.830*	78.43
2025-06-16	SELL	-885	83.000*	78.40 Profit of 69,380 on sale
2025-06-13	BUY	182	81.990*	78.37
2025-06-12	SELL	-728	82.850*	78.34 Profit of 57,028 on sale
2025-06-06	BUY	181	86.670*	78.13
2025-06-05	BUY	354	85.740*	78.07
2025-06-04	BUY	362	85.610*	78.01
2025-06-03	BUY	4,344	86.790*	77.94
2025-06-02	BUY	181	85.510*	77.88
2025-05-30	BUY	716	85.800*	77.82
2025-05-29	SELL	-181	84.860*	77.76 Profit of 14,075 on sale
2025-05-28	SELL	-181	86.980*	77.69 Profit of 14,061 on sale
2025-05-23	SELL	-362	84.510*	77.51 Profit of 28,058 on sale
2025-05-22	SELL	-1,448	84.830*	77.45 Profit of 112,145 on sale
2025-05-20	SELL	-177	87.340*	77.30 Profit of 13,682 on sale
2025-05-19	BUY	354	86.960*	77.22
2025-05-16	BUY	181	85.480*	77.14
2025-05-15	BUY	1,641	85.670*	77.07
2025-05-14	BUY	366	86.520*	76.99
2025-05-13	BUY	1,632	84.110*	76.92
2025-05-12	BUY	1,281	85.050*	76.85
2025-05-08	BUY	549	85.340*	76.70
2025-05-02	BUY	366	81.620*	76.51
2025-04-29	BUY	732	71.300*	76.67
2025-04-28	BUY	1,269	71.180*	76.73
2025-04-25	BUY	549	71.660*	76.78
2025-04-24	BUY	366	70.780*	76.84
2025-04-23	BUY	366	66.860*	76.94
2025-04-22	BUY	1,281	66.330*	77.05
2025-04-16	BUY	366	68.730*	77.44
2025-04-15	BUY	915	69.230*	77.53
2025-04-14	BUY	2,196	67.390*	77.64
2025-04-11	BUY	720	66.140*	77.77
2025-04-09	BUY	1,980	66.840*	78.01
2025-04-08	BUY	3,600	60.690*	78.21
2025-04-04	SELL	-2,347	59.830*	78.62 Profit of 184,523 on sale
2025-04-02	SELL	-179	68.140*	78.75 Profit of 14,095 on sale
2025-04-01	SELL	-179	67.320*	78.88 Profit of 14,120 on sale
2025-03-31	SELL	-1,247	68.290*	79.01 Profit of 98,528 on sale
2025-03-26	BUY	1,609	72.130*	79.36
2025-03-25	BUY	1,981	73.550*	79.44
2025-03-24	BUY	543	75.320*	79.49
2025-03-21	BUY	11,379	73.800*	79.57
2025-03-20	BUY	358	75.110*	79.63
2025-03-19	BUY	1,396	73.380*	79.71
2025-03-18	BUY	358	70.700*	79.83
2025-03-17	SELL	-537	71.350*	79.95 Profit of 42,934 on sale
2025-03-14	BUY	895	70.690*	80.08
2025-03-13	BUY	358	68.480*	80.25
2025-03-11	SELL	-990	70.260*	80.53 Profit of 79,728 on sale
2025-03-10	SELL	-885	70.720*	80.68 Profit of 71,402 on sale
2025-03-06	SELL	-885	79.510*	80.74 Profit of 71,456 on sale
2025-03-05	SELL	-352	81.960*	80.72 Profit of 28,414 on sale
2025-03-04	SELL	-1,584	82.420*	80.70 Profit of 127,822 on sale
2025-03-03	SELL	-829	85.990*	80.61 Profit of 66,826 on sale
2025-02-28	SELL	-511	88.370*	80.48 Profit of 41,127 on sale
2025-02-25	SELL	-704	88.320*	80.06 Profit of 56,361 on sale
2025-02-20	SELL	-352	89.340*	79.54 Profit of 27,997 on sale
2025-02-19	SELL	-1,056	89.680*	79.35 Profit of 83,793 on sale
2025-02-18	SELL	-528	90.530*	79.14 Profit of 41,785 on sale
2025-02-13	BUY	352	84.090*	78.64
2025-02-07	BUY	352	88.080*	77.95
2025-01-29	BUY	704	86.430*	76.23
2025-01-28	BUY	176	88.350*	75.91
2025-01-27	SELL	-17	87.530*	75.60 Profit of 1,285 on sale
2025-01-24	BUY	528	88.750*	75.23
2025-01-23	SELL	-7,392	87.700*	74.88 Profit of 553,488 on sale
2025-01-22	BUY	511	87.090*	74.52
2024-12-10	BUY	181	79.410*	74.37
2024-12-09	SELL	-1,267	78.410*	74.24 Profit of 94,066 on sale
2024-12-06	BUY	720	77.720*	74.13
2024-12-05	BUY	180	78.920*	73.97
2024-12-03	SELL	-720	80.910*	73.47 Profit of 52,900 on sale
2024-12-02	BUY	360	79.310*	73.26
2024-11-29	BUY	532	77.990*	73.07
2024-11-27	BUY	362	78.100*	72.65
2024-11-26	BUY	181	77.940*	72.42
2024-11-22	BUY	554	72.830*	72.15
2024-11-21	BUY	181	74.460*	72.03
2024-11-19	BUY	543	74.880*	71.70
2024-11-18	BUY	2,134	76.270*	71.43
2024-11-12	BUY	720	74.340*	71.25
2024-11-08	BUY	180	69.960*	71.40
2024-11-07	BUY	4,475	68.910*	71.60
2024-11-06	BUY	537	68.610*	71.84
2024-11-05	BUY	179	69.000*	72.10
2024-11-04	BUY	360	69.700*	72.34
2024-10-25	BUY	362	73.440*	73.26
2024-10-24	SELL	-362	74.850*	72.72 Profit of 26,326 on sale
2024-10-21	BUY	543	72.610*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DXCM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	2,244,349	123,900	7,301,108	30.7%
2025-09-18	2,096,398	2,923	4,473,314	46.9%
2025-09-17	1,005,017	909	2,841,630	35.4%
2025-09-16	832,635	1,252	1,662,428	50.1%
2025-09-15	415,979	19,554	1,507,100	27.6%
2025-09-12	479,180	25	1,013,014	47.3%
2025-09-11	1,239,171	19	3,292,844	37.6%
2025-09-10	778,899	1	2,102,775	37.0%
2025-09-09	398,555	48,137	1,042,556	38.2%
2025-09-08	597,379	10,948	1,743,480	34.3%
2025-09-05	490,229	0	992,181	49.4%
2025-09-04	833,267	24	1,699,659	49.0%
2025-09-03	1,673,104	582	3,096,450	54.0%
2025-09-02	559,125	6,032	1,379,296	40.5%
2025-08-29	395,483	819	767,429	51.5%
2025-08-28	480,565	39	1,612,270	29.8%
2025-08-27	422,875	756	1,106,762	38.2%
2025-08-26	451,911	15,387	1,316,342	34.3%
2025-08-25	801,886	5,802	2,158,071	37.2%
2025-08-22	279,355	5	826,312	33.8%
2025-08-21	331,378	4,639	798,573	41.5%
2025-08-20	491,337	399	1,003,276	49.0%
2025-08-19	311,145	1,383	842,816	36.9%
2025-08-18	509,896	0	1,182,266	43.1%
2025-08-15	351,714	12,102	630,748	55.8%
2025-08-14	394,332	438	858,593	45.9%
2025-08-13	530,063	302	1,270,620	41.7%
2025-08-12	533,812	115	1,296,848	41.2%
2025-08-11	673,352	144	1,432,682	47.0%
2025-08-08	812,111	647	1,314,352	61.8%
2025-08-07	679,883	11	1,091,906	62.3%
2025-08-06	902,331	283	2,029,615	44.5%
2025-08-05	598,249	68	2,057,698	29.1%
2025-08-04	942,525	17	3,002,291	31.4%
2025-08-01	1,104,059	1,225	2,117,218	52.1%
2025-07-31	1,973,583	3,744	3,201,771	61.6%
2025-07-30	484,427	82	1,520,136	31.9%
2025-07-29	414,317	112	885,534	46.8%
2025-07-28	545,711	900	1,158,616	47.1%
2025-07-25	439,501	851	1,018,375	43.2%
2025-07-24	314,578	49	750,090	41.9%
2025-07-23	342,609	311	689,820	49.7%
2025-07-22	354,194	17,613	750,057	47.2%
2025-07-21	308,164	9,508	783,241	39.3%
2025-07-18	312,697	18,442	836,608	37.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares NASDAQ 100 UCITS ETF USD (Acc)
Issuer	Blackrock
ETF Ticker	CNX1(GBX) LSE
ETF Ticker	SXRV(EUR) F
ETF Ticker	CNDX.AS(EUR) CXE
ETF Ticker	CNDX.LS(USD) CXE
ETF Ticker	CNX1.LS(GBX) CXE
ETF Ticker	CSNDX.MI(EUR) CXE
ETF Ticker	CSNDXz(USD) CXE
ETF Ticker	SXRV.DE(EUR) CXE
ETF Ticker	CSNDX(EUR) ETF Plus
ETF Ticker	CNDX(EUR) Euronext Amsterdam
ETF Ticker	CNX1.L(GBP) LSE